Literature DB >> 16174065

Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan.

Khalid Mumtaz1, Saeed S Hamid, Salman Adil, Asim Afaq, M Islam, Shahab Abid, Hasnain A Shah, Wasim Jafri.   

Abstract

BACKGROUND AND AIMS: The global epidemiology of hepatitis delta virus (HDV) infection is changing. This study was performed to determine the epidemiology and clinical impact of hepatitis delta in Pakistan.
METHODS: Countrywide data was collected from 1994 to 2001. A total of 8721 patients were tested for hepatitis delta antibody. A subset of 97 hepatitis delta antibody reactive inpatients with chronic liver disease were compared to 97 patients admitted with liver disease due to hepatitis B alone.
RESULTS: Of the 8721 patients tested, 1444 (16.6%) were reactive for hepatitis delta antibody. Most were males (87.4%, P < 0.001) and younger (mean age 31 years, P < 0.001) compared to HDV non-reactive patients. Prevalence of delta infection was highest in the rural (range 25-60%) compared to the urban population (range 6.5-11%). Analysis of the inpatient data showed that delta infected patients had significantly less severe clinical liver disease and a trend towards lesser development of hepatocellular carcinoma compared to delta negative patients.
CONCLUSIONS: (i) HDV infection is present in 16.6% of hepatitis B infected patients in Pakistan, most commonly in younger males living in rural areas; and (ii) delta virus infected patients have less severe clinical liver disease compared to delta negative, hepatitis B patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174065     DOI: 10.1111/j.1440-1746.2005.03857.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  26 in total

1.  Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon.

Authors:  S Ramia; M El-Zaatari; A I Sharara; F Ramlawi; B Farhat
Journal:  Epidemiol Infect       Date:  2006-12-19       Impact factor: 2.451

2.  Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases.

Authors:  Behrooz Ataei; Mohammad Reza Yazdani; Hamid Kalantari; Majid Yaran; Zary Nokhodian; Abbas Ali Javadi; Anahita Babak; Peyman Adibi
Journal:  Hepat Mon       Date:  2011-04-01       Impact factor: 0.660

3.  Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.

Authors:  Tatyana Kushner; Marina Serper; David E Kaplan
Journal:  J Hepatol       Date:  2015-05-08       Impact factor: 25.083

4.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

Review 5.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

6.  Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial.

Authors:  Zaigham Abbas; Mohammad Sadik Memon; Muhammad Amir Umer; Minaam Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2016-05-18

7.  Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan.

Authors:  Gulshan Zaidi; Muhammad Idrees; Fayyaz Ahmed Malik; Irum Amin; Muhammad Shahid; Saima Younas; Rashid Hussain; Zunaira Awan; Aaliyah Tariq; Khalida Parveen
Journal:  Virol J       Date:  2010-10-26       Impact factor: 4.099

8.  Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response.

Authors:  Shaikh Samiullah; Devrajani Bikharam
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

9.  Clinical presentation and genotype of hepatitis delta in Karachi.

Authors:  Tariq Moatter; Zaigham Abbas; Sabhita Shabir; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

10.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.